TNSN00045A1 - Derives de camptothecine a activite antitumorale - Google Patents

Derives de camptothecine a activite antitumorale

Info

Publication number
TNSN00045A1
TNSN00045A1 TNTNSN00045A TNSN00045A TNSN00045A1 TN SN00045 A1 TNSN00045 A1 TN SN00045A1 TN TNSN00045 A TNTNSN00045 A TN TNSN00045A TN SN00045 A TNSN00045 A TN SN00045A TN SN00045 A1 TNSN00045 A1 TN SN00045A1
Authority
TN
Tunisia
Prior art keywords
tumor activity
formula
camptothecin derivatives
revealed
compounds
Prior art date
Application number
TNTNSN00045A
Other languages
English (en)
Inventor
Sergio Penco
Paolo Carminati
Lucio Merlini
Franco Zunino
Original Assignee
Sigma Tau Ind Farmaceuti
Ist Naz Stud Cura Dei Tumori
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti, Ist Naz Stud Cura Dei Tumori filed Critical Sigma Tau Ind Farmaceuti
Publication of TNSN00045A1 publication Critical patent/TNSN00045A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

LES DERIVES DE CAMPTOTHECINES DE LA FORMULE (I) : OU LES GROUPEMENTS R1, R2 ET R3 SONT REVELES TELS QUE DEFINIS DANS LA DESCRIPTION. LES COMPOSES DE LA FORMULE (I) SONT DOTES D'UNE ACTIVITE ANTITUMORALE ET PRESENTENT UN BON INDICE THERAPEUTIQUE. SONT EGALEMENT REVELES DES PROCEDES POUR LA PREPARATION DES COMPOSES DE LA FORMULE (I) ET LEUR UTILISATION DANS LA PREPARATION DE MEDICAMENTS UTILES POUR LE TRAITEMENT DES TUMEURS, INFECTIONS VIRALES ET DE L'ANTIPLASMODIUM FALCIPARUM.
TNTNSN00045A 1999-03-09 2000-03-08 Derives de camptothecine a activite antitumorale TNSN00045A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99830124A EP1044977B1 (fr) 1999-03-09 1999-03-09 Dérivés de camptothécine à activité anti-tumorale

Publications (1)

Publication Number Publication Date
TNSN00045A1 true TNSN00045A1 (fr) 2005-11-10

Family

ID=8243303

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN00045A TNSN00045A1 (fr) 1999-03-09 2000-03-08 Derives de camptothecine a activite antitumorale

Country Status (39)

Country Link
US (2) US6242457B1 (fr)
EP (1) EP1044977B1 (fr)
JP (1) JP4610743B2 (fr)
KR (1) KR100702085B1 (fr)
CN (1) CN1139592C (fr)
AR (1) AR022860A1 (fr)
AT (1) ATE216998T1 (fr)
AU (1) AU774174B2 (fr)
BG (1) BG65032B1 (fr)
BR (1) BR0008840B1 (fr)
CA (1) CA2362760C (fr)
CO (1) CO5180590A1 (fr)
CZ (1) CZ304465B6 (fr)
DE (1) DE69901379T2 (fr)
DK (1) DK1044977T3 (fr)
EA (1) EA003605B1 (fr)
EE (1) EE04679B1 (fr)
EG (1) EG23999A (fr)
ES (1) ES2175919T3 (fr)
HK (1) HK1031222A1 (fr)
HR (1) HRP20010667B1 (fr)
HU (1) HU229506B1 (fr)
IL (2) IL144958A0 (fr)
IS (1) IS2003B (fr)
ME (2) ME00017B (fr)
MX (1) MXPA01009081A (fr)
NO (1) NO328363B1 (fr)
NZ (1) NZ513393A (fr)
PE (1) PE20001485A1 (fr)
PL (1) PL222208B1 (fr)
PT (1) PT1044977E (fr)
RS (1) RS50405B (fr)
SI (1) SI1044977T1 (fr)
SK (1) SK287561B6 (fr)
TN (1) TNSN00045A1 (fr)
TR (1) TR200102603T2 (fr)
TW (1) TWI272272B (fr)
WO (1) WO2000053607A1 (fr)
ZA (1) ZA200107408B (fr)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE376824T1 (de) 1999-01-13 2007-11-15 Alchemia Oncology Pty Ltd Verwendung von hyaluronan zur herstellung eines medikaments zur erhöhung der wirksamkeit von zytotoxischen arzneimitteln
US7105492B2 (en) * 1999-03-09 2006-09-12 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Camptothecin derivatives having antitumor activity
FR2794123B1 (fr) * 1999-05-28 2001-07-27 Aventis Pharma Sa Preparation de derives de la camptothecine et de la nothapodytine
US6352996B1 (en) * 1999-08-03 2002-03-05 The Stehlin Foundation For Cancer Research Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs
AUPQ879500A0 (en) * 2000-07-14 2000-08-10 Meditech Research Limited Hyaluronan as cytotoxic agent, drug presensitizer and chemo-sensitizer in the treatment of disease
US9066919B2 (en) * 2000-07-14 2015-06-30 Alchemia Oncology Pty Limited Hyaluronan as a chemo-sensitizer in the treatment of cancer
US20040029906A1 (en) * 2001-07-31 2004-02-12 Michael Christman Inhibitors of dna polymerase sigma
WO2003018062A1 (fr) * 2001-08-27 2003-03-06 Meditech Research Limited Protocoles therapeutiques ameliores
WO2003033525A1 (fr) * 2001-10-12 2003-04-24 Debio Recherche Pharmacuetique S.A. Derives polymeres de camptothecine amino-substitues et utilisation de ceux-ci pour la fabrication d'un medicament
ITRM20020306A1 (it) * 2002-05-31 2003-12-01 Sigma Tau Ind Farmaceuti Esteri in posizione 20 di camptotecine.
ITRM20020305A1 (it) * 2002-05-31 2003-12-01 Sigma Tau Ind Farmaceuti Camptotecine con anello lattonico modificato.
FR2852606A1 (fr) * 2003-03-18 2004-09-24 Inst Nat Sante Rech Med Moyens pour inhiber simultanement l'expression de plusieurs genes impliques dans une pathologie
US20040204435A1 (en) * 2003-04-09 2004-10-14 Joachim Liehr Alternating treatment with topoisomerase I and topoisomerase II inhibitors
ITRM20030344A1 (it) * 2003-07-14 2005-01-15 Ist Naz Stud Cura Dei Tumori 7-n-poliamminoalchil(ossi)imminometilcamptotecine recanti gruppi protettivi.
AU2005226932B2 (en) * 2004-03-26 2009-07-09 Novartis Ag Use of camptothecin derivates for the treatment of proliferative diseases in a fixed dosing regimen
JP5170741B2 (ja) 2004-04-27 2013-03-27 ウェルスタット バイオロジクス コーポレイション ウイルスおよびカンプトテシン類を使用する癌の処置
ITRM20040240A1 (it) * 2004-05-13 2004-08-13 Ist Naz Stud Cura Dei Tumori Camptotecine coniugate in posizione 7 con antagonisti delle integrine.
ITRM20040242A1 (it) * 2004-05-13 2004-08-13 Ist Naz Stud Cura Dei Tumori "7-t-butossiimminometilcamptotecina coniugata in posizione 20 con antagonisti delle integrine.
ITRM20040241A1 (it) * 2004-05-13 2004-08-13 Ist Naz Stud Cura Dei Tumori Camptotecine coniugate in posizione 20 con antagonisti delle integrine.
ITRM20040288A1 (it) * 2004-06-11 2004-09-11 Sigma Tau Ind Farmaceuti Uso della 7-t-butossiimminometilcamptotecina per la preparazione di un medicamento per il trattamento delle neoplasie dell'utero.
CN100334089C (zh) * 2004-07-21 2007-08-29 王洋 一种9－硝基喜树碱的生产方法
GT200500310A (es) * 2004-11-19 2006-06-19 Compuestos organicos
US8975248B2 (en) * 2004-12-15 2015-03-10 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Combinations of therapeutic agents for treating cancer
DK1828196T3 (da) * 2004-12-21 2012-11-26 Sigma Tau Ind Farmaceuti Stereospecifik fremgangsmåde og krystallinske former af en camptothecin
SA06270147B1 (ar) 2005-06-09 2009-12-22 نوفارتيس ايه جي عملية لتخليق 5-(مثيل–1h–إيميدازول–1-يل )–3-(ثلاثي فلـورو مثيل)–بنزامـين
RU2435586C2 (ru) 2005-07-14 2011-12-10 Веллстат Байолоджикс Корпорейшн Лечение рака с применением вирусов, фторпиримидинов и камптотецинов
CA2616607C (fr) * 2005-07-27 2015-06-02 Alchemia Oncology Pty Limited Protocoles therapeutiques utilisant hyaluronan
ITRM20050418A1 (it) * 2005-08-04 2007-02-05 Sigma Tau Ind Farmaceuti Sistemi terapeutici a rilascio immediato per il migliorato assorbimento orale di 7-[(e)-t-butilossimminometil] camptotecina.
MX2008001970A (es) * 2005-08-10 2008-03-24 Novartis Ag Formulaciones para 7-(t-butoxi)iminometil camptotecin.
JP5627181B2 (ja) * 2005-09-07 2014-11-19 アルケミア オンコロジー ピーティーワイ リミテッド ヒアルロナンおよび治療用抗体を含む治療用組成物ならびに治療方法
DK1962850T3 (da) * 2005-12-21 2012-06-18 Sigma Tau Ind Farmaceuti Behandling af lægemiddelresistente tumorer
CN101421282B (zh) * 2006-02-17 2013-08-14 俄勒冈州由俄勒冈州立大学代表高等教育委员会行使 用长春花生物碱n-氧化物和类似物治疗过度增殖性疾病
JP5313867B2 (ja) 2006-03-30 2013-10-09 ドライス ファーマシューティカルズ，インコーポレイティド カンプトテシン−細胞透過性ペプチド複合体及びそれを含む医薬組成物
WO2008094959A1 (fr) * 2007-02-01 2008-08-07 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Composition pharmaceutique comprenant un dérivé de camptothécine
US8853233B2 (en) * 2007-02-13 2014-10-07 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Broad-spectrum anti-cancer treatment based on iminocamptothecin derivatives
CA2694389C (fr) * 2007-08-01 2016-01-19 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A Traitement de tumeurs pediatriques
EP2096113A1 (fr) 2008-02-05 2009-09-02 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Dérivés de camptothécine substitués 9 en tant que composants antitumeurs
TWI482621B (zh) 2009-12-23 2015-05-01 Sigma Tau Ind Farmaceuti 青蒿素基藥物與其他化學治療劑的抗癌組合物
EP3352796A4 (fr) 2015-09-25 2019-05-01 ZY Therapeutics Inc. Formulation médicamenteuse à base de particules comprenant un conjugué polysaccharide-vitamine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4399276A (en) * 1981-01-09 1983-08-16 Kabushiki Kaisha Yakult Honsha 7-Substituted camptothecin derivatives
DK0612248T3 (da) * 1991-11-15 2003-12-08 Smithkline Beecham Corp Præparat, der indeholder cisplatin og topotecan som antitumormiddel
US5614529A (en) * 1994-09-22 1997-03-25 Research Triangle Institute Inhibition of plasmodia parasites by camptothecin compounds
US5972955A (en) * 1995-06-06 1999-10-26 Dr. Reddy's Research Foundation Water soluble C-ring analogues of 20(S)-camptothecin
GB9512670D0 (en) * 1995-06-21 1995-08-23 Sod Conseils Rech Applic Camptothecin analogues
IT1282673B1 (it) * 1996-02-23 1998-03-31 Ist Naz Stud Cura Dei Tumori Derivati della camptotecina e loro uso come agenti antitumorali
AU718799C (en) * 1996-08-19 2004-02-12 Bionumerik Pharmaceuticals, Inc. Highly lipophilic camptothecin derivatives

Also Published As

Publication number Publication date
EA200100954A1 (ru) 2002-04-25
DK1044977T3 (da) 2002-07-08
BR0008840B1 (pt) 2011-12-27
US6242457B1 (en) 2001-06-05
HRP20010667B1 (en) 2003-06-30
RS50405B (sr) 2009-12-31
AU3160400A (en) 2000-09-28
US6589939B2 (en) 2003-07-08
SK287561B6 (sk) 2011-02-04
HU229506B1 (en) 2014-01-28
TWI272272B (en) 2007-02-01
EE200100466A (et) 2002-12-16
EP1044977B1 (fr) 2002-05-02
BR0008840A (pt) 2002-01-08
IL144958A (en) 2009-08-03
HRP20010667A2 (en) 2002-08-31
HUP0200210A2 (hu) 2002-05-29
CN1139592C (zh) 2004-02-25
HUP0200210A3 (en) 2004-03-29
NO328363B1 (no) 2010-02-01
PT1044977E (pt) 2002-09-30
IS6031A (is) 2001-07-31
IS2003B (is) 2005-04-15
ZA200107408B (en) 2002-05-29
MXPA01009081A (es) 2002-08-30
CZ304465B6 (cs) 2014-05-21
KR100702085B1 (ko) 2007-04-02
BG105810A (en) 2002-06-28
WO2000053607A1 (fr) 2000-09-14
EA003605B1 (ru) 2003-06-26
NO20014128D0 (no) 2001-08-24
ES2175919T3 (es) 2002-11-16
KR20010102519A (ko) 2001-11-15
YU64301A (sh) 2005-07-19
EP1044977A1 (fr) 2000-10-18
AU774174B2 (en) 2004-06-17
ATE216998T1 (de) 2002-05-15
US20010008939A1 (en) 2001-07-19
AR022860A1 (es) 2002-09-04
CA2362760A1 (fr) 2000-09-14
ME00017B (fr) 2010-06-10
NO20014128L (no) 2001-08-24
CN1343209A (zh) 2002-04-03
SI1044977T1 (en) 2002-08-31
PE20001485A1 (es) 2000-12-07
EE04679B1 (et) 2006-08-15
MEP4008A (xx) 2010-02-10
JP4610743B2 (ja) 2011-01-12
JP2002539128A (ja) 2002-11-19
NZ513393A (en) 2003-04-29
EG23999A (en) 2008-03-19
PL355094A1 (en) 2004-03-22
BG65032B1 (bg) 2006-12-29
DE69901379D1 (de) 2002-06-06
PL222208B1 (pl) 2016-07-29
HK1031222A1 (en) 2001-06-08
CO5180590A1 (es) 2002-07-30
TR200102603T2 (tr) 2002-01-21
CA2362760C (fr) 2009-08-18
DE69901379T2 (de) 2002-11-07
CZ20013077A3 (cs) 2002-01-16
IL144958A0 (en) 2002-06-30
SK11642001A3 (sk) 2002-01-07

Similar Documents

Publication Publication Date Title
TNSN00045A1 (fr) Derives de camptothecine a activite antitumorale
FR2686084B1 (fr) Nouveaux derives de l'imidazole, leur preparation et leurs applications therapeutiques.
NL970006I2 (nl) Gebruik van indolon-derivaten voor het bereiden van geneesmiddelen ter behandeling van de ziekte vanParkinson.
DK0975595T3 (da) Kokainanaloger
TNSN98045A1 (fr) Derives de nicotinamide nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
DE69223914D1 (de) 4-substituierte-2-Deoxy-2,3-Didehydro Alpha-D-Neuraminsäure antivirale Derivate
NZ516347A (en) Indanyl-substituted benzenecarboxamides, process for their preparation, their use as a medicament and pharmaceutical formulations containing them
BG103947A (en) Derivatives of 9-oxymerythromycin
GEP20033081B (en) Pharmaceutical Agents for Treatment of Parkinson's Disease, ADFD and Microadenomas
IT1226727B (it) Farmaci precursori della dopamina.
MA23639A1 (fr) Derives pyrrocarbazole, leur preparation, les compositions pharmaceutiques les contenant, leur utilisation dans le traitement des tumeurs malignes.
TNSN87012A1 (fr) Nouveaux derives de dihydrobenzofuranne - et de chromane - carboxamides, leurs procedes de preparation et leur utilisation comme neuroleptiques
MY133112A (en) 3-amino-3-arylpropan-1-ol derivatives, and their preparation and use
ES2144054T3 (es) Complejos de tri(platino).
TNSN90021A1 (fr) Procede de preparation de tetrahydroimidazo (1,4) benzodiazepin -2- thiones antivirales
FR2699176B1 (fr) Nouveaux composés bicycliques de pyrimidine, leur procédé de préparation et les compositions pharmaceutiques les renfermant.
OA07063A (fr) Nouveaux dérivés d'aminéothoxy-4 isopropy-5 méthyl-2 phénol, leur méthodes de préparation et leur emploi comme médicaments.
BE902796A (fr) Ester d'acetyl carnitine, sa preparation et son utilisation.
CA2318848A1 (fr) Derives de 5'-deoxycytidine
TNSN01001A1 (fr) NOUVELLES PYRAZOLO [4,3-e] DIAZEPINES SUBSTITUEES, COMPOSITIONS PHARMACEUTIQUES LES CONTENANT, UTILISATION A TITRE DE MEDICAMENT ET PROCEDES POUR LEUR PREPARATION
TNSN00211A1 (fr) Derives d'hygromycine a nouveaux, compositions les contenant et leur utilisation
FR2722789B1 (fr) Derives d'acide imidazo (1,2-a)indeno(1,2-e) pyrazine-2-carboxylique, leur preparation et les medicaments les contenant
FR2383176A1 (fr) Amino aryl triazines 1-2-4 utilisables dans le traitement d'algies diverses
IT1223395B (it) Composti ad attivita' cardiovascolare
FR2412564A1 (fr) Nouvelles 2' -n-acyl- et alkyl-6' -n-alkyl- et 6', 6' -di-n-alkyl-fortimicines a et b, utiles notamment comme antibiotiques